Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.
|Slideshows|July 8, 2016
Interesting Neuro: Parkinson Rates & Zika News
Author(s)Samantha J. Peterson
Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.
Advertisement
We present a selection of interesting neurology articles for the month of July in the following slides. See the slide legends for links to the article summaries.
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 30, 2026.
A study of deceased former NFL players estimated that nearly 75% had CTE neuropathology, while a phase 3 trial is evaluating whether F-18 FNT-PET imaging could help identify disease-associated patterns in living patients.
An analysis of the PROSPECT trial reported that consistent use of transcutaneous afferent patterned stimulation was associated with improvement in underlying tremor severity in patients with essential tremor.
The FDA has approved asundexian, the first factor XIa inhibitor indicated to reduce recurrent stroke after a noncardioembolic ischemic stroke or high-risk TIA, based on phase 3 OCEANIC-STROKE data.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Factor XIa Inhibitor Asundexian for Secondary Stroke Prevention
2
FDA Investigates Confirmed Insertional Oncogenesis With Spinal Muscular Atrophy Gene Therapy
3
Examining High-Dose Influenza Vaccination and Alzheimer Disease Risk
4
PrimeC Lowers Neuron-Derived TDP-43, Informing Phase 3 PARAGON Trial in ALS
5